SQUIRE SLEEP SYSTEMS CLOSES SECOND ROUND OF FUNDING

 
Contact: John Schultz
FOR IMMEDIATE RELEASE
Office: 206-547-0447
Seattle - August 1, 2012

Email:john@squiresleep.com

 
SQUIRE SLEEP SYSTEMS CLOSES SECOND ROUND OF FUNDING
Squire Sleep Systems, a sleep therapy company with a revolutionary sleep apnea mattress, today announced the closing of a second round of funding. The investment terms were not disclosed, however, this internal investment round values the company at $2.5M. The round will accelerate Squire Sleep Systems’ growth as it delivers its first product to the marketplace in August 2012 and was completed by Fenwick & West LLP – A national technology and life sciences law firm. The third round of funding will be open to accredited investors in the US with a focus on strategic partners.

Squire Sleep Systems has developed a patented solution to the age old problem of how to sleep comfortably on your side. The Sleep System is designed for side sleeping, and puts the body at an incline. The patented arm-channel allows the sleep system to align the spine of the human body while sleeping, and put the lower back in mild traction. Stress on the arm and shoulder joints are reduced so sleepers are able to find better comfort and a more restful sleep. Squire Sleep Systems is investigating the efficacy of the Squire Sleep System in the treatment of Positional Obstructive Sleep Apnea and other sleep related health issues.

Our technology platform is capable of delivering revolutionary therapy for a wide variety of sleep related health problems. Obstructive Sleep Apnea (OSA) is a highly prevalent and chronic condition that has significant health, psychological, and financial consequences for the 40 million adults in the U.S. with the disease, 80% of them undiagnosed. Squire Sleep Systems can treat millions of patients at a lower cost than other treatments with greater adherence.

For further information, please contact:
Squire Sleep Systems, John W. Schultz, CEO 206-547-0447 john@squiresleep.com